The diverse roles of macrophages in metabolic inflammation and its resolution

Macrophages are one of the most functionally diverse immune cells, indispensable to maintain tissue integrity and metabolic health. Macrophages perform a myriad of functions ranging from promoting inflammation, through inflammation resolution to restoring and maintaining tissue homeostasis. Metabolic diseases encompass a growing list of diseases which develop from a mix of genetics and environmental cues leading to metabolic dysregulation and subsequent inflammation. In this review, we summarize the contributions of macrophages to four metabolic conditions–insulin resistance and adipose tissue inflammation, atherosclerosis, non-alcoholic fatty liver disease and neurodegeneration. The role of macrophages is complex, yet they hold great promise as potential therapies to address these growing health concerns.

[1]  T. Langmann,et al.  Past history of obesity triggers persistent epigenetic changes in innate immunity and exacerbates neuroinflammation , 2023, Science.

[2]  M. Yeh,et al.  Genetic deletion or pharmacologic inhibition of the Nlrp3 inflammasome did not ameliorate experimental NASH , 2023, Journal of lipid research.

[3]  K. Ley,et al.  Deleting interleukin-10 from myeloid cells exacerbates atherosclerosis in Apoe−/− mice , 2022, Cellular and Molecular Life Sciences.

[4]  Y. Hoshida,et al.  Prolonged hypernutrition impairs TREM2-dependent efferocytosis to license chronic liver inflammation and NASH development. , 2022, Immunity.

[5]  Konstantin Zaitsev,et al.  Trem2 promotes foamy macrophage lipid uptake and survival in atherosclerosis , 2022, bioRxiv.

[6]  I. Tabas,et al.  CD47-SIRPα axis blockade in NASH promotes necroptotic hepatocyte clearance by liver macrophages and decreases hepatic fibrosis , 2022, Science Translational Medicine.

[7]  Bin Zhao,et al.  Gas6 Promotes Microglia Efferocytosis and Suppresses Inflammation Through Activating Axl/Rac1 Signaling in Subarachnoid Hemorrhage Mice. , 2022, Translational stroke research.

[8]  Ortal Tuvali,et al.  Circulating Soluble TREM2 and Cardiovascular Outcome in Cohort Study of Coronary Atherosclerosis Patients , 2022, International journal of molecular sciences.

[9]  Xiao Zhang,et al.  Microglial hexokinase 2 deficiency increases ATP generation through lipid metabolism leading to β-amyloid clearance , 2022, Nature Metabolism.

[10]  L. Lau,et al.  Cellular communication network factor 1‐stimulated liver macrophage efferocytosis drives hepatic stellate cell activation and liver fibrosis , 2022, Hepatology communications.

[11]  I. Amit,et al.  Dual ontogeny of disease-associated microglia and disease inflammatory macrophages in aging and neurodegeneration. , 2022, Immunity.

[12]  A. Hasty,et al.  Weight cycling induces innate immune memory in adipose tissue macrophages , 2022, bioRxiv.

[13]  M. Krawczyk,et al.  Soluble TREM2 levels reflect the recruitment and expansion of TREM2+ macrophages that localize to fibrotic areas and limit NASH. , 2022, Journal of hepatology.

[14]  D. Brenner,et al.  MiR-690 treatment causes decreased fibrosis and steatosis and restores specific Kupffer cell functions in NASH. , 2022, Cell metabolism.

[15]  Nathan C. Winn,et al.  Multiomics reveals persistence of obesity-associated immune cell phenotypes in adipose tissue during weight loss and weight regain in mice , 2022, Nature communications.

[16]  K. Yaffe,et al.  Risk Factors Associated With Alzheimer Disease and Related Dementias by Sex and Race and Ethnicity in the US. , 2022, JAMA neurology.

[17]  D. Wasserman,et al.  Cyclooxygenase-2 in adipose tissue macrophages limits adipose tissue dysfunction in obese mice , 2022, The Journal of clinical investigation.

[18]  M. Reilly,et al.  Myeloid LXR (Liver X Receptor) Deficiency Induces Inflammatory Gene Expression in Foamy Macrophages and Accelerates Atherosclerosis , 2022, Arteriosclerosis, thrombosis, and vascular biology.

[19]  Faith H. Brennan,et al.  Microglia maintain the normal structure and function of the hippocampal astrocyte network , 2022, Glia.

[20]  T. Höllt,et al.  Co-expression patterns of microglia markers Iba1, TMEM119 and P2RY12 in Alzheimer's disease , 2021, Neurobiology of Disease.

[21]  A. Tall,et al.  Macrophages Use Apoptotic Cell-Derived Methionine and DNMT3A During Efferocytosis to Promote Tissue Resolution , 2022, Nature Metabolism.

[22]  C. Giannarelli,et al.  ATVB IN FOCUS: Single-Cell Sequencing Technologies , 2022 .

[23]  Jacqueline M. Roberts,et al.  Neuronal apoptosis drives remodeling states of microglia and shifts in survival pathway dependence , 2022, bioRxiv.

[24]  H. Cordell,et al.  Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease. , 2021, Journal of hepatology.

[25]  A. Niraula,et al.  Prostaglandin PGE2 receptor EP4 regulates microglial phagocytosis and increases susceptibility to diet-induced obesity , 2021, bioRxiv.

[26]  N. Leeper,et al.  Macrophage LRP1 (Low-Density Lipoprotein Receptor-Related Protein 1) Is Required for the Effect of CD47 Blockade on Efferocytosis and Atherogenesis—Brief Report , 2021, Arteriosclerosis, thrombosis, and vascular biology.

[27]  Wei Ying,et al.  Adipose Tissue Macrophages Modulate Obesity-Associated β Cell Adaptations through Secreted miRNA-Containing Extracellular Vesicles , 2021, Cells.

[28]  F. Ginhoux,et al.  A subset of Kupffer cells regulates metabolism through the expression of CD36. , 2021, Immunity.

[29]  B. Baban,et al.  Beige adipocytes mediate the neuroprotective and anti-inflammatory effects of subcutaneous fat in obese mice , 2021, Nature Communications.

[30]  Yong Xu,et al.  Low serum Maresin-1 levels are associated with non-alcoholic fatty liver disease: a cross-sectional study , 2021, Lipids in Health and Disease.

[31]  Julia J. Mack,et al.  FXR activation protects against NAFLD via bile-acid-dependent reductions in lipid absorption. , 2021, Cell metabolism.

[32]  L. Ng,et al.  Resident macrophages restrain pathological adipose tissue remodeling and protect vascular integrity in obese mice , 2021, EMBO reports.

[33]  Hao Ji,et al.  Macrophage tumor necrosis factor-alpha deletion does not protect against obesity-associated metabolic dysfunction , 2021, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[34]  B. Staels,et al.  PPAR control of metabolism and cardiovascular functions , 2021, Nature Reviews Cardiology.

[35]  Jasmin Herz,et al.  Skull and vertebral bone marrow are myeloid cell reservoirs for the meninges and CNS parenchyma , 2021, Science.

[36]  B. Naini,et al.  T‐Cell Immunoglobulin and Mucin Domain‐Containing Protein‐4 Is Critical for Kupffer Cell Homeostatic Function in the Activation and Resolution of Liver Ischemia Reperfusion Injury , 2021, Hepatology.

[37]  P. Libby,et al.  Targeting inflammation in atherosclerosis — from experimental insights to the clinic , 2021, Nature Reviews Drug Discovery.

[38]  Chiadi E. Ndumele,et al.  Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association , 2021, Circulation.

[39]  B. Heit,et al.  Cellular Responses to the Efferocytosis of Apoptotic Cells , 2021, Frontiers in Immunology.

[40]  Kelly V. Ruggles,et al.  Wnt signaling enhances macrophage responses to IL-4 and promotes resolution of atherosclerosis , 2021, eLife.

[41]  K. Moore,et al.  miR-33 Silencing Reprograms the Immune Cell Landscape in Atherosclerotic Plaques , 2021, Circulation research.

[42]  M. Colonna,et al.  TREM2 sustains macrophage-hepatocyte metabolic coordination in nonalcoholic fatty liver disease and sepsis. , 2021, The Journal of clinical investigation.

[43]  E. Fisher,et al.  Atherosclerosis Regression and Cholesterol Efflux in Hypertriglyceridemic Mice. , 2021, Circulation research.

[44]  S. Klein,et al.  Dynamic Shifts in the Composition of Resident and Recruited Macrophages Influence Tissue Remodeling in NASH , 2021, Cell reports.

[45]  J. Olefsky,et al.  MiR-690, an exosomal-derived miRNA from M2-polarized macrophages, improves insulin sensitivity in obese mice. , 2021, Cell metabolism.

[46]  O. Elemento,et al.  Diet-regulated production of PDGFcc by macrophages controls energy storage , 2021, Science.

[47]  K. Hirschi,et al.  Tissue-Resident Macrophage Development and Function , 2021, Frontiers in Cell and Developmental Biology.

[48]  A. Sobrino,et al.  Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators , 2020, PloS one.

[49]  Steffen Jung,et al.  A Binary Cre Transgenic Approach Dissects Microglia and CNS Border-Associated Macrophages. , 2020, Immunity.

[50]  C. Still,et al.  The relationship between specialized pro-resolving lipid mediators, morbid obesity and weight loss after bariatric surgery , 2020, Scientific Reports.

[51]  D. Mozaffarian,et al.  Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk: The STRENGTH Randomized Clinical Trial. , 2020, JAMA.

[52]  Xiaoyu Hu,et al.  MicroRNAs of the miR-17~92 family maintain adipose tissue macrophage homeostasis by sustaining IL-10 expression , 2020, eLife.

[53]  Mingyao Li,et al.  Single-Cell Genomics Reveals a Novel Cell State During Smooth Muscle Cell Phenotypic Switching and Potential Therapeutic Targets for Atherosclerosis in Mouse and Human , 2020, Circulation.

[54]  Y. Saeys,et al.  Osteopontin Expression Identifies a Subset of Recruited Macrophages Distinct from Kupffer Cells in the Fatty Liver , 2020, Immunity.

[55]  Jing Yan,et al.  lncRNA-SNHG14 Promotes Atherosclerosis by Regulating RORα Expression through Sponge miR-19a-3p , 2020, Comput. Math. Methods Medicine.

[56]  Maxim N. Artyomov,et al.  Limited proliferation capacity of aorta intima resident macrophages requires monocyte recruitment for atherosclerotic plaque progression , 2020, Nature Immunology.

[57]  B. Jana,et al.  Novel mechanism of cholesterol transport by ABCA5 in macrophages and its role in dyslipidaemia. , 2020, Journal of molecular biology.

[58]  M. Cybulsky,et al.  Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas , 2020, Circulation research.

[59]  Enzhao Liu,et al.  MicroRNA-124 inhibits macrophage cell apoptosis via targeting p38/MAPK signaling pathway in atherosclerosis development , 2020, Aging.

[60]  Jonathan D. Smith,et al.  IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes , 2020, Nature Immunology.

[61]  G. Marcelin,et al.  Impaired Kupffer Cell Self-Renewal Alters the Liver Response to Lipid Overload during Non-alcoholic Steatohepatitis. , 2020, Immunity.

[62]  D. Cai,et al.  Reversal of prolonged obesity-associated cerebrovascular dysfunction by inhibiting microglial Tak1 , 2020, Nature Neuroscience.

[63]  J. Alemán,et al.  Treatment of Obesity in Mitigating Metabolic Risk. , 2020, Circulation research.

[64]  K. Moore,et al.  Leukocyte Heterogeneity in Adipose Tissue, Including in Obesity. , 2020, Circulation research.

[65]  Cheol‐Min Park,et al.  N-AS-triggered SPMs are direct regulators of microglia in a model of Alzheimer’s disease , 2020, Nature Communications.

[66]  C. Glass,et al.  Niche-Specific Reprogramming of Epigenetic Landscapes Drives Myeloid Cell Diversity in Nonalcoholic Steatohepatitis. , 2020, Immunity.

[67]  Zhaohui Chai,et al.  Inhibition of miR-19a-3p decreases cerebral ischemia/reperfusion injury by targeting IGFBP3 in vivo and in vitro , 2020, Biological Research.

[68]  G. Shulman,et al.  Regulation of adipose tissue inflammation by interleukin 6 , 2020, Proceedings of the National Academy of Sciences.

[69]  B. Becher,et al.  Plaque-associated myeloid cells derive from resident microglia in an Alzheimer’s disease model , 2020, The Journal of experimental medicine.

[70]  Scott B. Crown,et al.  Macrophage Metabolism of Apoptotic Cell-Derived Arginine Promotes Continual Efferocytosis and Resolution of Injury. , 2020, Cell metabolism.

[71]  B. Baban,et al.  Visceral adipose NLRP3 impairs cognition in obesity via IL1R1 on Cx3cr1+ cells. , 2020, The Journal of clinical investigation.

[72]  Steve Lianoglou,et al.  TREM2 Regulates Microglial Cholesterol Metabolism upon Chronic Phagocytic Challenge , 2019, Neuron.

[73]  Ganesh V. Halade,et al.  Resolvin E1 derived from eicosapentaenoic acid prevents hyperinsulinemia and hyperglycemia in a host genetic manner , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[74]  U. Hedin,et al.  MicroRNA-144 Silencing Protects Against Atherosclerosis in Male, but Not Female Mice , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[75]  R. Schwabe,et al.  Macrophage MerTK Promotes Liver Fibrosis in Nonalcoholic Steatohepatitis. , 2019, Cell metabolism.

[76]  H. Cao,et al.  Lipotoxic Hepatocyte-Derived Exosomal miR-192-5p Activates Macrophages via Rictor/Akt/FoxO1 Signaling in NAFLD. , 2019, Hepatology.

[77]  S. Chernausek,et al.  Macrophage‐Derived microRNA‐155 Increases in Obesity and Influences Adipocyte Metabolism by Targeting Peroxisome Proliferator‐Activated Receptor Gamma , 2019, Obesity.

[78]  J. Tijssen,et al.  The effect of low-dose colchicine in patients with stable coronary artery disease: The LoDoCo2 trial rationale, design, and baseline characteristics. , 2019, American heart journal.

[79]  Jun Chen,et al.  STAT6/Arg1 promotes microglia/macrophage efferocytosis and inflammation resolution in stroke mice. , 2019, JCI insight.

[80]  Nicolas F. Fernandez,et al.  Single-cell immune landscape of human atherosclerotic plaques , 2019, Nature Medicine.

[81]  C. Glass,et al.  Liver-Derived Signals Sequentially Reprogram Myeloid Enhancers to Initiate and Maintain Kupffer Cell Identity. , 2019, Immunity.

[82]  E. Fisher,et al.  Role of LpL(Lipoprotein Lipase) in Macrophage Polarization In Vitro and In Vivo. , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[83]  K. Moore,et al.  Single-Cell RNA Sequencing of Visceral Adipose Tissue Leukocytes Reveals that Caloric Restriction Following Obesity Promotes the Accumulation of a Distinct Macrophage Population with Features of Phagocytic Cells , 2019, Immunometabolism.

[84]  I. Amit,et al.  Lipid-Associated Macrophages Control Metabolic Homeostasis in a Trem2-Dependent Manner , 2019, Cell.

[85]  M. Alexander,et al.  The role of macrophages in the resolution of inflammation. , 2019, The Journal of clinical investigation.

[86]  K. Rayner,et al.  Resolvin D1 promotes the targeting and clearance of necroptotic cells , 2019, Cell Death & Differentiation.

[87]  J. Cha,et al.  A maresin 1/ROR&agr;/12-lipoxygenase autoregulatory circuit prevents inflammation and progression of nonalcoholic steatohepatitis , 2019, The Journal of clinical investigation.

[88]  K. Cadwell,et al.  Vasculature-associated fat macrophages readily adapt to inflammatory and metabolic challenges , 2019, The Journal of experimental medicine.

[89]  S. Ramsey,et al.  Single-cell analysis of fate-mapped macrophages reveals heterogeneity, including stem-like properties, during atherosclerosis progression and regression. , 2019, JCI insight.

[90]  P. Libby,et al.  Low‐Dose Methotrexate for the Prevention of Atherosclerotic Events , 2019, The New England journal of medicine.

[91]  Zhiren Zhang,et al.  The deficiency of macrophage erythropoietin signaling contributes to delayed acute inflammation resolution in diet-induced obese mice. , 2019, Biochimica et biophysica acta. Molecular basis of disease.

[92]  J. Lykkesfeldt,et al.  A role of peroxisome proliferator‐activated receptor γ in non‐alcoholic fatty liver disease , 2019, Basic & clinical pharmacology & toxicology.

[93]  Deepak L. Bhatt,et al.  Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia , 2019, The New England journal of medicine.

[94]  E. Fisher,et al.  Methods to Study Monocyte and Macrophage Trafficking in Atherosclerosis Progression and Resolution. , 2019, Methods in molecular biology.

[95]  F. Song,et al.  Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. , 2018, The Cochrane database of systematic reviews.

[96]  Maxim N. Artyomov,et al.  Transcriptome Analysis Reveals Nonfoamy Rather Than Foamy Plaque Macrophages Are Proinflammatory in Atherosclerotic Murine Models , 2018, Circulation research.

[97]  P. Libby,et al.  Modulation of the interleukin-6 signalling pathway and incidence rates of atherosclerotic events and all-cause mortality: analyses from the Canakinumab Anti-Inflammatory Thrombosis Outcomes Study (CANTOS) , 2018, European heart journal.

[98]  G. Gusarova,et al.  Regulatory T Cells Promote Macrophage Efferocytosis during Inflammation Resolution , 2018, Immunity.

[99]  Yang Zhao,et al.  The origins and homeostasis of monocytes and tissue‐resident macrophages in physiological situation , 2018, Journal of cellular physiology.

[100]  R. Birge,et al.  MerTK signaling in macrophages promotes the synthesis of inflammation resolution mediators by suppressing CaMKII activity , 2018, Science Signaling.

[101]  T. Luedde,et al.  Apoptosis and necroptosis in the liver: a matter of life and death , 2018, Nature Reviews Gastroenterology & Hepatology.

[102]  Charlotte L. Scott,et al.  Macrophages and lipid metabolism , 2018, Cellular immunology.

[103]  A. Kennedy,et al.  Macrophage-Targeted Therapeutics for Metabolic Disease. , 2018, Trends in pharmacological sciences.

[104]  M. Heming,et al.  Peroxisome Proliferator-Activated Receptor-γ Modulates the Response of Macrophages to Lipopolysaccharide and Glucocorticoids , 2018, Front. Immunol..

[105]  G. Adema,et al.  Lipid Droplets as Immune Modulators in Myeloid Cells. , 2018, Trends in immunology.

[106]  James J. Campbell,et al.  CC chemokine receptor 2 promotes recruitment of myeloid cells associated with insulin resistance in nonalcoholic fatty liver disease. , 2018, American journal of physiology. Gastrointestinal and liver physiology.

[107]  T. Luedde,et al.  Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis , 2018, Hepatology.

[108]  Dennis Wolf,et al.  Atlas of the Immune Cell Repertoire in Mouse Atherosclerosis Defined by Single-Cell RNA-Sequencing and Mass Cytometry , 2018, Circulation research.

[109]  Dennis Wolf,et al.  Single-Cell RNA-Seq Reveals the Transcriptional Landscape and Heterogeneity of Aortic Macrophages in Murine Atherosclerosis , 2018, Circulation research.

[110]  M. Moreno-Aliaga,et al.  Maresin 1 mitigates liver steatosis in ob/ob and diet-induced obese mice , 2018, International Journal of Obesity.

[111]  Eric J. Brunner,et al.  Obesity trajectories and risk of dementia: 28 years of follow-up in the Whitehall II Study , 2018, Alzheimer's & Dementia.

[112]  B. Barres,et al.  Microglia and macrophages in brain homeostasis and disease , 2017, Nature Reviews Immunology.

[113]  M. Nagarkatti,et al.  MicroRNA-30 modulates metabolic inflammation by regulating notch signaling in adipose tissue macrophages , 2018, International Journal of Obesity.

[114]  J. Fish,et al.  Extracellular Vesicles Secreted by Atherogenic Macrophages Transfer MicroRNA to Inhibit Cell Migration , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[115]  M. Fessler.  The challenges and promise of targeting the Liver X Receptors for treatment of inflammatory disease , 2018, Pharmacology & therapeutics.

[116]  C. Stehouwer,et al.  Adipose tissue macrophages induce hepatic neutrophil recruitment and macrophage accumulation in mice , 2017, Gut.

[117]  Jong Bae Seo,et al.  Adipose Tissue Macrophage-Derived Exosomal miRNAs Can Modulate In Vivo and In Vitro Insulin Sensitivity , 2017, Cell.

[118]  A. Shah,et al.  Metabolically Activated Adipose Tissue Macrophages Perform Detrimental and Beneficial Functions during Diet-Induced Obesity. , 2017, Cell reports.

[119]  R. Eckel,et al.  Lipoprotein Lipase Maintains Microglial Innate Immunity in Obesity. , 2017, Cell reports.

[120]  C. Gross,et al.  Microglia remodel synapses by presynaptic trogocytosis and spine head filopodia induction , 2017, Nature Communications.

[121]  P. Libby,et al.  Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease , 2017, The New England journal of medicine.

[122]  J. Clària,et al.  The specialized proresolving lipid mediator maresin 1 protects hepatocytes from lipotoxic and hypoxia‐induced endoplasmic reticulum stress , 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[123]  K. Moore,et al.  Inflammatory Ly6Chi monocytes and their conversion to M2 macrophages drive atherosclerosis regression , 2017, The Journal of clinical investigation.

[124]  B. Barres,et al.  Microglial Inflammatory Signaling Orchestrates the Hypothalamic Immune Response to Dietary Excess and Mediates Obesity Susceptibility. , 2017, Cell metabolism.

[125]  S. Gordon,et al.  Tissue macrophages: heterogeneity and functions , 2017, BMC Biology.

[126]  I. Amit,et al.  A Unique Microglia Type Associated with Restricting Development of Alzheimer’s Disease , 2017, Cell.

[127]  Tom R. Gaunt,et al.  Causal Associations of Adiposity and Body Fat Distribution With Coronary Heart Disease, Stroke Subtypes, and Type 2 Diabetes Mellitus: A Mendelian Randomization Analysis , 2017, Circulation.

[128]  D. Kober,et al.  TREM2-Ligand Interactions in Health and Disease. , 2017, Journal of molecular biology.

[129]  Rachel C. Bandler,et al.  microRNA-33 Regulates Macrophage Autophagy in Atherosclerosis , 2017, Arteriosclerosis, thrombosis, and vascular biology.

[130]  G. Fredman,et al.  Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy. , 2017, The American journal of pathology.

[131]  S. Subramanian,et al.  Cholesterol crystallization within hepatocyte lipid droplets and its role in murine NASH[S] , 2017, Journal of Lipid Research.

[132]  C. Ballantyne,et al.  The Upregulation of Integrin αDβ2 (CD11d/CD18) on Inflammatory Macrophages Promotes Macrophage Retention in Vascular Lesions and Development of Atherosclerosis , 2017, The Journal of Immunology.

[133]  P. Reddy,et al.  Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[134]  Huimin Wu,et al.  Effect of modulation of PPAR-γ activity on Kupffer cells M1/M2 polarization in the development of non-alcoholic fatty liver disease , 2017, Scientific Reports.

[135]  M. Daemen,et al.  MerTK receptor cleavage promotes plaque necrosis and defective resolution in atherosclerosis , 2017, The Journal of clinical investigation.

[136]  Manoj Kumar,et al.  INGE GRUNDKE-IQBAL AWARD FOR ALZHEIMER’S RESEARCH: NEUROTOXIC REACTIVE ASTROCYTES ARE INDUCED BY ACTIVATED MICROGLIA , 2019, Alzheimer's & Dementia.

[137]  Yanni Lv,et al.  MicroRNA-27a Negatively Modulates the Inflammatory Response in Lipopolysaccharide-Stimulated Microglia by Targeting TLR4 and IRAK4 , 2017, Cellular and Molecular Neurobiology.

[138]  K. Vickers,et al.  Lipoprotein carriers of microRNAs. , 2016, Biochimica et biophysica acta.

[139]  R. Thandavarayan,et al.  MicroRNA-126 overexpression rescues diabetes-induced impairment in efferocytosis of apoptotic cardiomyocytes , 2016, Scientific Reports.

[140]  M. Linton,et al.  Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis. , 2016, Circulation journal : official journal of the Japanese Circulation Society.

[141]  B. Bibby,et al.  The macrophage activation marker sCD163 is associated with morphological disease stages in patients with non‐alcoholic fatty liver disease , 2016, Liver international : official journal of the International Association for the Study of the Liver.

[142]  David M. Jones,et al.  An imbalance between specialized pro-resolving lipid mediators and pro-inflammatory leukotrienes promotes instability of atherosclerotic plaques , 2016, Nature Communications.

[143]  V. Arroyo,et al.  Signaling and Immunoresolving Actions of Resolvin D1 in Inflamed Human Visceral Adipose Tissue , 2016, The Journal of Immunology.

[144]  F. Nevens,et al.  FXR agonist obeticholic acid reduces hepatic inflammation and fibrosis in a rat model of toxic cirrhosis , 2016, Scientific Reports.

[145]  Y. Yoshimura,et al.  Microglia contact induces synapse formation in developing somatosensory cortex , 2016, Nature Communications.

[146]  R. Zimmer,et al.  Resolving Lipid Mediators Maresin 1 and Resolvin D2 Prevent Atheroprogression in Mice. , 2016, Circulation research.

[147]  R. Reimer,et al.  Kupffer Cells Undergo Fundamental Changes during the Development of Experimental NASH and Are Critical in Initiating Liver Damage and Inflammation , 2016, PloS one.

[148]  E. Fisher,et al.  Divergent JAM-C Expression Accelerates Monocyte-Derived Cell Exit from Atherosclerotic Plaques , 2016, PloS one.

[149]  F. Heppner,et al.  High-fat diet-induced brain region-specific phenotypic spectrum of CNS resident microglia , 2016, Acta Neuropathologica.

[150]  Jens-Peter Volkmer,et al.  CD47 blocking antibodies restore phagocytosis and prevent atherosclerosis , 2016, Nature.

[151]  N. LeBrasseur,et al.  CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis , 2016, Scientific Reports.

[152]  F. Carrilho,et al.  Omega-3 polyunsaturated fatty acids in treating non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled trial. , 2016, Clinical nutrition.

[153]  S. Harrison,et al.  Effect of Weight Loss, Diet, Exercise, and Bariatric Surgery on Nonalcoholic Fatty Liver Disease. , 2016, Clinics in liver disease.

[154]  John M. Davis,et al.  Re-evaluation of the traditional diet-heart hypothesis: analysis of recovered data from Minnesota Coronary Experiment (1968-73) , 2016, British Medical Journal.

[155]  G. Gores,et al.  Lipid-Induced Signaling Causes Release of Inflammatory Extracellular Vesicles From Hepatocytes. , 2016, Gastroenterology.

[156]  Z. Wang,et al.  Obesity is an independent risk factor for non‐alcoholic fatty liver disease: evidence from a meta‐analysis of 21 cohort studies , 2016, Obesity reviews : an official journal of the International Association for the Study of Obesity.

[157]  C. Tripodo,et al.  MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease. , 2016, Journal of hepatology.

[158]  G. Gores,et al.  Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes , 2016, Hepatology.

[159]  Á. Chamorro,et al.  Immature monocytes recruited to the ischemic mouse brain differentiate into macrophages with features of alternative activation , 2016, Brain, Behavior, and Immunity.

[160]  K. Moore,et al.  MicroRNA Regulation of Atherosclerosis. , 2016, Circulation research.

[161]  M. Bennett,et al.  Vascular Smooth Muscle Cells in Atherosclerosis. , 2016, Circulation research.

[162]  A. Arj,et al.  Prediction of Nonalcoholic Fatty Liver Disease Via a Novel Panel of Serum Adipokines , 2016, Medicine.

[163]  Y. Saeys,et al.  Bone marrow-derived monocytes give rise to self-renewing and fully differentiated Kupffer cells , 2016, Nature Communications.

[164]  Mariana Vargas-Caballero,et al.  Pharmacological targeting of CSF1R inhibits microglial proliferation and prevents the progression of Alzheimer’s-like pathology , 2016, Brain : a journal of neurology.

[165]  B. Levy,et al.  Specialized pro-resolving mediators: endogenous regulators of infection and inflammation , 2015, Nature Reviews Immunology.

[166]  Carla M. T. Bauer,et al.  Self-renewing resident arterial macrophages arise from embryonic CX3CR1+ precursors and circulating monocytes immediately after birth , 2015, Nature Immunology.

[167]  D. Huso,et al.  Activation of liver X receptor/retinoid X receptor pathway ameliorates liver disease in Atp7B−/− (Wilson disease) mice , 2015, Hepatology.

[168]  A. Granholm,et al.  Pro-Resolving Lipid Mediators Improve Neuronal Survival and Increase Aβ42 Phagocytosis , 2016, Molecular Neurobiology.

[169]  S. Safe,et al.  MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative macrophage activation. , 2015, The Journal of clinical investigation.

[170]  Pardis C Sabeti,et al.  Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis , 2015, Nature Medicine.

[171]  S. Younkin,et al.  Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)* , 2015, The Journal of Biological Chemistry.

[172]  F. Nevens,et al.  Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease. , 2015, Gastroenterology.

[173]  K. Clément,et al.  Macrophage activation marker soluble CD163 and non‐alcoholic fatty liver disease in morbidly obese patients undergoing bariatric surgery , 2015, Journal of gastroenterology and hepatology.

[174]  Christopher J. Cheng,et al.  miR-155 Is Essential for Inflammation-Induced Hippocampal Neurogenic Dysfunction , 2015, The Journal of Neuroscience.

[175]  K. Kodys,et al.  MicroRNA-155 Deficiency Attenuates Liver Steatosis and Fibrosis without Reducing Inflammation in a Mouse Model of Steatohepatitis , 2015, PloS one.

[176]  Laura S. Shankman,et al.  KLF4 Dependent Phenotypic Modulation of SMCs Plays a Key Role in Atherosclerotic Plaque Pathogenesis , 2015, Nature Medicine.

[177]  F. Ginhoux,et al.  C-Myb(+) erythro-myeloid progenitor-derived fetal monocytes give rise to adult tissue-resident macrophages. , 2015, Immunity.

[178]  B. Neuschwander‐Tetri,et al.  Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial , 2015, The Lancet.

[179]  M. Xie,et al.  TREM2 regulates microglial cell activation in response to demyelination in vivo , 2015, Acta Neuropathologica.

[180]  A. Tall,et al.  Cholesterol, inflammation and innate immunity , 2015, Nature Reviews Immunology.

[181]  J. Palmblad,et al.  Resolution of inflammation is altered in Alzheimer's disease , 2015, Alzheimer's & Dementia.

[182]  F. Geissmann,et al.  Tissue-resident macrophages originate from yolk-sac-derived erythro-myeloid progenitors , 2014, Nature.

[183]  H. Kwon,et al.  Adipocyte-Specific IKKβ Signaling Suppresses Adipose Tissue Inflammation through an IL-13-Dependent Paracrine Feedback Pathway , 2014, Cell reports.

[184]  Xiong Ma,et al.  FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation. , 2014, World journal of gastroenterology.

[185]  R. Evans,et al.  Characterization of Distinct Subpopulations of Hepatic Macrophages in HFD/Obese Mice , 2014, Diabetes.

[186]  Í. Lopes-Cendes,et al.  Fractalkine (CX3CL1) Is Involved in the Early Activation of Hypothalamic Inflammation in Experimental Obesity , 2014, Diabetes.

[187]  K. Moore,et al.  miR33 Inhibition Overcomes Deleterious Effects of Diabetes Mellitus on Atherosclerosis Plaque Regression in Mice , 2014, Circulation research.

[188]  P. Calder,et al.  Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: Results from the WELCOME* study , 2014, Hepatology.

[189]  Youwen Tan,et al.  A Pilot Study of Serum MicroRNAs Panel as Potential Biomarkers for Diagnosis of Nonalcoholic Fatty Liver Disease , 2014, PloS one.

[190]  Jessica L. Cohen,et al.  Lipid storage by adipose tissue macrophages regulates systemic glucose tolerance. , 2014, American journal of physiology. Endocrinology and metabolism.

[191]  O. Cummings,et al.  No significant effects of ethyl-eicosapentanoic acid on histologic features of nonalcoholic steatohepatitis in a phase 2 trial. , 2014, Gastroenterology.

[192]  A. Sanyal,et al.  Circulating microRNA signature in non-alcoholic fatty liver disease: from serum non-coding RNAs to liver histology and disease pathogenesis , 2014, Gut.

[193]  C. Bing,et al.  Interleukin-1β mediates macrophage-induced impairment of insulin signaling in human primary adipocytes , 2014, American journal of physiology. Endocrinology and metabolism.

[194]  A. Wree,et al.  NLRP3 inflammasome activation is required for fibrosis development in NAFLD , 2014, Journal of Molecular Medicine.

[195]  Peter Tontonoz,et al.  Liver X receptors in lipid metabolism: opportunities for drug discovery , 2014, Nature Reviews Drug Discovery.

[196]  A. Tall,et al.  Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. , 2014, Cell metabolism.

[197]  S. Allahverdian,et al.  Contribution of Intimal Smooth Muscle Cells to Cholesterol Accumulation and Macrophage-Like Cells in Human Atherosclerosis , 2014, Circulation.

[198]  Q. Wang,et al.  An Agomir of miR-144-3p Accelerates Plaque Formation through Impairing Reverse Cholesterol Transport and Promoting Pro-Inflammatory Cytokine Production , 2014, PloS one.

[199]  K. Irvine,et al.  The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease , 2014, Hepatology.

[200]  K. Moore,et al.  Netrin-1 promotes adipose tissue macrophage accumulation and insulin resistance in obesity , 2014, Nature Medicine.

[201]  C. Davis,et al.  Obesity Elicits Interleukin 1-Mediated Deficits in Hippocampal Synaptic Plasticity , 2014, The Journal of Neuroscience.

[202]  V. Arroyo,et al.  Resolvin D1 primes the resolution process initiated by calorie restriction in obesity‐induced steatohepatitis , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[203]  Ryan Berry,et al.  Weighing in on adipocyte precursors. , 2014, Cell metabolism.

[204]  T. Schall,et al.  Experimental evidence for the use of CCR2 antagonists in the treatment of type 2 diabetes. , 2013, Metabolism: clinical and experimental.

[205]  Y. Barak,et al.  Cell-specific PPARγ deficiency establishes anti-inflammatory and anti-fibrogenic properties for this nuclear receptor in non-parenchymal liver cells. , 2013, Journal of hepatology.

[206]  S. Mudaliar,et al.  Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease. , 2013, Gastroenterology.

[207]  M. Murkovic,et al.  Food-derived peroxidized fatty acids may trigger hepatic inflammation: a novel hypothesis to explain steatohepatitis. , 2013, Journal of hepatology.

[208]  M. Rane,et al.  Increased Saturated Fatty Acids in Obesity Alter Resolution of Inflammation in Part by Stimulating Prostaglandin Production , 2013, The Journal of Immunology.

[209]  A. Hevener,et al.  Reciprocal regulation of hepatic and adipose lipogenesis by liver X receptors in obesity and insulin resistance. , 2013, Cell metabolism.

[210]  Yuanhui Ma,et al.  Activated Cyclin-Dependent Kinase 5 Promotes Microglial Phagocytosis of Fibrillar β-Amyloid by Up-regulating Lipoprotein Lipase Expression* , 2013, Molecular & Cellular Proteomics.

[211]  T. Hibi,et al.  C‐C motif chemokine receptor 9 positive macrophages activate hepatic stellate cells and promote liver fibrosis in mice , 2013, Hepatology.

[212]  P. Libby,et al.  Local proliferation dominates lesional macrophage accumulation in atherosclerosis , 2013, Nature Medicine.

[213]  C. Serhan,et al.  Diversity of lipid mediators in human adipose tissue depots. , 2013, American journal of physiology. Cell physiology.

[214]  P. Edwards,et al.  MicroRNA-144 Regulates Hepatic ATP Binding Cassette Transporter A1 and Plasma High-Density Lipoprotein After Activation of the Nuclear Receptor Farnesoid X Receptor , 2013, Circulation research.

[215]  X. Ji,et al.  MiRNA-424 Protects Against Permanent Focal Cerebral Ischemia Injury in Mice Involving Suppressing Microglia Activation , 2013, Stroke.

[216]  G. Ioannou,et al.  Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis[S] , 2013, Journal of Lipid Research.

[217]  K. Moore,et al.  Neuroimmune Guidance Cue Semaphorin 3E Is Expressed in Atherosclerotic Plaques and Regulates Macrophage Retention , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[218]  A. Schober,et al.  The microRNA-342-5p Fosters Inflammatory Macrophage Activation Through an Akt1- and microRNA-155–Dependent Pathway During Atherosclerosis , 2013, Circulation.

[219]  I. Goldberg,et al.  Macrophage lipoprotein lipase modulates the development of atherosclerosis but not adiposity , 2013, Journal of Lipid Research.

[220]  J. Zavadil,et al.  Control of Cholesterol Metabolism and Plasma High-Density Lipoprotein Levels by microRNA-144 , 2013, Circulation research.

[221]  L. Solt,et al.  A liver-selective LXR inverse agonist that suppresses hepatic steatosis. , 2013, ACS chemical biology.

[222]  L. Adorini,et al.  Bile Acid Receptor Activation Modulates Hepatic Monocyte Activity and Improves Nonalcoholic Fatty Liver Disease* , 2013, The Journal of Biological Chemistry.

[223]  Hong Lu,et al.  Circulating miR-214 is associated with the severity of coronary artery disease , 2013, Journal of geriatric cardiology : JGC.

[224]  Kenneth A. Philbrick,et al.  Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis. , 2013, The Journal of nutrition.

[225]  John M Davis,et al.  Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis , 2013, BMJ : British Medical Journal.

[226]  E. Abraham,et al.  MicroRNAs in immune response and macrophage polarization. , 2013, Arteriosclerosis, thrombosis, and vascular biology.

[227]  A. Mildner,et al.  Fate mapping reveals origins and dynamics of monocytes and tissue macrophages under homeostasis. , 2013, Immunity.

[228]  M. Heneka,et al.  NLRP3 is activated in Alzheimer´s disease and contributes to pathology in APP/PS1 mice , 2012, Nature.

[229]  Z. Kutalik,et al.  Genome-wide association study identifies variants associated with progression of liver fibrosis from HCV infection. , 2012, Gastroenterology.

[230]  Virginia Nguyen,et al.  Kuppfer Cells Trigger Nonalcoholic Steatohepatitis Development in Diet-induced Mouse Model through Tumor Necrosis Factor-α Production* , 2012, The Journal of Biological Chemistry.

[231]  D. Ramji,et al.  TGF-β inhibits the uptake of modified low density lipoprotein by human macrophages through a Smad-dependent pathway: A dominant role for Smad-2 , 2012, Biochimica et biophysica acta.

[232]  O. Wagner,et al.  Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype , 2012, EMBO molecular medicine.

[233]  S. Safe,et al.  A Novel Regulator of Macrophage Activation: miR-223 in Obesity-Associated Adipose Tissue Inflammation , 2012, Circulation.

[234]  M. Hashizume,et al.  Atherogenic effects of TNF-α and IL-6 via up-regulation of scavenger receptors. , 2012, Cytokine.

[235]  C. Ramírez,et al.  miR-106b impairs cholesterol efflux and increases Aβ levels by repressing ABCA1 expression , 2012, Experimental Neurology.

[236]  N. Van Rooijen,et al.  Hepatic recruitment of macrophages promotes nonalcoholic steatohepatitis through CCR2. , 2012, American journal of physiology. Gastrointestinal and liver physiology.

[237]  Wei Wei,et al.  MiR‐26 controls LXR‐dependent cholesterol efflux by targeting ABCA1 and ARL7 , 2012, FEBS letters.

[238]  K. Drescher,et al.  Exosomal miRNAs: Biological Properties and Therapeutic Potential , 2012, Front. Gene..

[239]  J. Pollard,et al.  A Lineage of Myeloid Cells Independent of Myb and Hematopoietic Stem Cells , 2012, Science.

[240]  M. Hofker,et al.  Internalization of Modified Lipids by CD36 and SR-A Leads to Hepatic Inflammation and Lysosomal Cholesterol Storage in Kupffer Cells , 2012, PloS one.

[241]  R. Hu,et al.  Selective depletion of hepatic Kupffer cells significantly alleviated hepatosteatosis and intrahepatic inflammation induced by high fat diet. , 2012, Hepato-gastroenterology.

[242]  L. Pereira de Almeida,et al.  miR‐155 modulates microglia‐mediated immune response by down‐regulating SOCS‐1 and promoting cytokine and nitric oxide production , 2012, Immunology.

[243]  K. Moore,et al.  The neuroimmune guidance cue netrin-1 promotes atherosclerosis by inhibiting macrophage emigration from plaques , 2011, Nature Immunology.

[244]  Xiaofeng Han,et al.  Activation of Liver X Receptors Attenuates Endotoxin-Induced Liver Injury in Mice with Nonalcoholic Fatty Liver Disease , 2012, Digestive Diseases and Sciences.

[245]  A. Dávalos,et al.  MicroRNA-758 Regulates Cholesterol Efflux Through Posttranscriptional Repression of ATP-Binding Cassette Transporter A1 , 2011, Arteriosclerosis, thrombosis, and vascular biology.

[246]  K. Moore,et al.  Inhibition of miR-33a/b in non-human primates raises plasma HDL and reduces VLDL triglycerides , 2011, Nature.

[247]  S. Gortmaker,et al.  Health and economic burden of the projected obesity trends in the USA and the UK , 2011, The Lancet.

[248]  V. Jala,et al.  Deficiency of the Leukotriene B4 Receptor, BLT-1, Protects against Systemic Insulin Resistance in Diet-Induced Obesity , 2011, The Journal of Immunology.

[249]  T. Luedde,et al.  Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury , 2011, Gut.

[250]  Yunan Tang,et al.  Resolvin D1 decreases adipose tissue macrophage accumulation and improves insulin sensitivity in obese‐diabetic mice , 2011, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[251]  Aaron N. Chang,et al.  Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. , 2011, The Journal of clinical investigation.

[252]  E. Ravussin,et al.  The NALP3/NLRP3 Inflammasome Instigates Obesity-Induced Autoinflammation and Insulin Resistance , 2010, Nature Medicine.

[253]  A. Barnes.  The epidemic of obesity and diabetes: trends and treatments. , 2011, Texas Heart Institute journal.

[254]  P. Libby,et al.  Lack of EP4 receptors on bone marrow-derived cells enhances inflammation in atherosclerotic lesions. , 2011, Cardiovascular research.

[255]  S. Greenfeder,et al.  Inflammatory Signals shift from adipose to liver during high fat feeding and influence the development of steatohepatitis in mice , 2011, Journal of Inflammation.

[256]  Chaowei Wu,et al.  LXR promotes the maximal egress of monocyte-derived cells from mouse aortic plaques during atherosclerosis regression. , 2010, The Journal of clinical investigation.

[257]  F. Ginhoux,et al.  Fate Mapping Analysis Reveals That Adult Microglia Derive from Primitive Macrophages , 2010, Science.

[258]  Takeshi Kimura,et al.  MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo , 2010, Proceedings of the National Academy of Sciences.

[259]  Ashley M. Miller,et al.  Interleukin-33 Induces Protective Effects in Adipose Tissue Inflammation During Obesity in Mice , 2010, Circulation research.

[260]  I. Gérin,et al.  Expression of miR-33 from an SREBP2 Intron Inhibits Cholesterol Export and Fatty Acid Oxidation* , 2010, The Journal of Biological Chemistry.

[261]  P. Meikle,et al.  Interleukin-6-deficient mice develop hepatic inflammation and systemic insulin resistance , 2010, Diabetologia.

[262]  Ashley M. Miller,et al.  IL-33 Reduces Macrophage Foam Cell Formation , 2010, The Journal of Immunology.

[263]  G. Gores,et al.  Hepatocyte death: a clear and present danger. , 2010, Physiological reviews.

[264]  K. Moore,et al.  MiR-33 Contributes to the Regulation of Cholesterol Homeostasis , 2010, Science.

[265]  T. Shioda,et al.  MicroRNA-33 and the SREBP Host Genes Cooperate to Control Cholesterol Homeostasis , 2010, Science.

[266]  K. Moore,et al.  Role of scavenger receptor A and CD36 in diet-induced nonalcoholic steatohepatitis in hyperlipidemic mice. , 2010, Gastroenterology.

[267]  Luca Scalfi,et al.  Excess Body Weight and Incidence of Stroke: Meta-Analysis of Prospective Studies With 2 Million Participants , 2010, Stroke.

[268]  S. Sookoian,et al.  Circulating levels and hepatic expression of molecular mediators of atherosclerosis in nonalcoholic fatty liver disease. , 2010, Atherosclerosis.

[269]  S. Fiorucci,et al.  FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats[S] , 2010, Journal of Lipid Research.

[270]  Michael Müller,et al.  Kupffer cells promote hepatic steatosis via interleukin‐1β–dependent suppression of peroxisome proliferator‐activated receptor α activity , 2010, Hepatology.

[271]  S. Klein,et al.  Obesity and nonalcoholic fatty liver disease: Biochemical, metabolic, and clinical implications , 2010, Hepatology.

[272]  P. Giral,et al.  Long‐term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial , 2009, Hepatology.

[273]  H. Ginsberg,et al.  C-C Chemokine Receptor 2 (CCR2) Regulates the Hepatic Recruitment of Myeloid Cells That Promote Obesity-Induced Hepatic Steatosis , 2010, Diabetes.

[274]  N. Lanthier,et al.  Kupffer cell activation is a causal factor for hepatic insulin resistance. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[275]  J. Dubé,et al.  Depletion of Liver Kupffer Cells Prevents the Development of Diet-Induced Hepatic Steatosis and Insulin Resistance , 2009, Diabetes.

[276]  Brian C. Pridgen,et al.  Defective Phagocytosis of Apoptotic Cells by Macrophages in Atherosclerotic Lesions of ob/ob Mice and Reversal by a Fish Oil Diet , 2009, Circulation research.

[277]  I. Tabas,et al.  Mechanisms and consequences of efferocytosis in advanced atherosclerosis , 2009, Journal of leukocyte biology.

[278]  B. Blackman,et al.  Complex Regulation and Function of the Inflammatory Smooth Muscle Cell Phenotype in Atherosclerosis , 2009, Journal of Vascular Research.

[279]  K. Iwaisako,et al.  c-Jun N-terminal kinase-1 from hematopoietic cells mediates progression from hepatic steatosis to steatohepatitis and fibrosis in mice. , 2009, Gastroenterology.

[280]  R. Friedline,et al.  Interleukin-10 Prevents Diet-Induced Insulin Resistance by Attenuating Macrophage and Cytokine Response in Skeletal Muscle , 2009, Diabetes.

[281]  Patrice D Cani,et al.  Critical role of Kupffer cells in the management of diet-induced diabetes and obesity. , 2009, Biochemical and biophysical research communications.

[282]  F. Ginhoux,et al.  Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis , 2009, Hepatology.

[283]  O. Lindvall,et al.  Long‐term accumulation of microglia with proneurogenic phenotype concomitant with persistent neurogenesis in adult subventricular zone after stroke , 2009, Glia.

[284]  P. Libby,et al.  Obesity, inflammation, and atherosclerosis , 2009, Nature Reviews Cardiology.

[285]  V. Arroyo,et al.  Obesity‐induced insulin resistance and hepatic steatosis are alleviated by ω‐3 fatty acids: a role for resolvins and protectins , 2009, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[286]  H. Kadouh,et al.  Inhibition of the chemokine (C–C motif) ligand 2/chemokine (C–C motif) receptor 2 pathway attenuates hyperglycaemia and inflammation in a mouse model of hepatic steatosis and lipoatrophy , 2009, Diabetologia.

[287]  Y. Hirata,et al.  Role of CC Chemokine Receptor 2 in Bone Marrow Cells in the Recruitment of Macrophages into Obese Adipose Tissue* , 2008, Journal of Biological Chemistry.

[288]  J. Oates,et al.  Macrophage EP4 deficiency increases apoptosis and suppresses early atherosclerosis. , 2008, Cell metabolism.

[289]  K. Kotoh,et al.  Liver X receptor in cooperation with SREBP‐1c is a major lipid synthesis regulator in nonalcoholic fatty liver disease , 2008, Hepatology research : the official journal of the Japan Society of Hepatology.

[290]  A. E. Sippel,et al.  Effect of Macrophage Overexpression of Murine Liver X Receptor-α (LXR-α) on Atherosclerosis in LDL-Receptor Deficient Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[291]  D. Schrijvers,et al.  Mertk Receptor Mutation Reduces Efferocytosis Efficiency and Promotes Apoptotic Cell Accumulation and Plaque Necrosis in Atherosclerotic Lesions of Apoe−/− Mice , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[292]  A. Feldstein,et al.  Increased Hepatic and Circulating Interleukin-6 Levels in Human Nonalcoholic Steatohepatitis , 2008, The American Journal of Gastroenterology.

[293]  A. Tall,et al.  HDL, ABC transporters, and cholesterol efflux: implications for the treatment of atherosclerosis. , 2008, Cell metabolism.

[294]  C. McNamara,et al.  Role of smooth muscle cells in the initiation and early progression of atherosclerosis. , 2008, Arteriosclerosis, thrombosis, and vascular biology.

[295]  T. Aoyama,et al.  Highly Purified Eicosapentaenoic Acid Treatment Improves Nonalcoholic Steatohepatitis , 2008, Journal of clinical gastroenterology.

[296]  T. Simon,et al.  Combined Inhibition of CCL2, CX3CR1, and CCR5 Abrogates Ly6Chi and Ly6Clo Monocytosis and Almost Abolishes Atherosclerosis in Hypercholesterolemic Mice , 2008, Circulation.

[297]  Ashley M. Miller,et al.  IL-33 reduces the development of atherosclerosis , 2008, The Journal of experimental medicine.

[298]  V. de Waard,et al.  Combined Deletion of Macrophage ABCA1 and ABCG1 Leads to Massive Lipid Accumulation in Tissue Macrophages and Distinct Atherosclerosis at Relatively Low Plasma Cholesterol Levels , 2007, Arteriosclerosis, thrombosis, and vascular biology.

[299]  M. Karin,et al.  JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity. , 2007, Cell metabolism.

[300]  Michelle M Wiest,et al.  A lipidomic analysis of nonalcoholic fatty liver disease , 2007, Hepatology.

[301]  A. Tall,et al.  High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1 , 2007, Proceedings of the National Academy of Sciences.

[302]  O. McGuinness,et al.  Macrophage TNF-α contributes to insulin resistance and hepatic steatosis in diet-induced obesity , 2007 .

[303]  S. Haulon,et al.  PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties. , 2007, Cell metabolism.

[304]  Frank Brombacher,et al.  Macrophage-specific PPARγ controls alternative activation and improves insulin resistance , 2007, Nature.

[305]  C. Glass,et al.  Macrophage PPAR gamma is required for normal skeletal muscle and hepatic insulin sensitivity and full antidiabetic effects of thiazolidinediones. , 2007, The Journal of clinical investigation.

[306]  L. Fésüs,et al.  PPARγ‐dependent regulation of human macrophages in phagocytosis of apoptotic cells , 2007, European journal of immunology.

[307]  Allan Vaag,et al.  Interleukin-1-receptor antagonist in type 2 diabetes mellitus. , 2007, The New England journal of medicine.

[308]  N. Mitro,et al.  The nuclear receptor LXR is a glucose sensor , 2007, Nature.

[309]  F. Tacke,et al.  Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques. , 2007, The Journal of clinical investigation.

[310]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[311]  P. Libby,et al.  Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata. , 2007, The Journal of clinical investigation.

[312]  Christian Weber,et al.  Ccr5 But Not Ccr1 Deficiency Reduces Development of Diet-Induced Atherosclerosis in Mice , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[313]  L. Piccio,et al.  Cutting Edge: TREM-2 Attenuates Macrophage Activation1 , 2006, The Journal of Immunology.

[314]  T. Kadowaki,et al.  Overexpression of Monocyte Chemoattractant Protein-1 in Adipose Tissues Causes Macrophage Recruitment and Insulin Resistance* , 2006, Journal of Biological Chemistry.

[315]  M. Cybulsky,et al.  Low-grade chronic inflammation in regions of the normal mouse arterial intima predisposed to atherosclerosis , 2006, The Journal of experimental medicine.

[316]  M. Leduc,et al.  Potential role of microglia in retinal blood vessel formation. , 2006, Investigative ophthalmology & visual science.

[317]  R. Kitazawa,et al.  MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity. , 2006, The Journal of clinical investigation.

[318]  P. Calder,et al.  n-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. , 2006, The American journal of clinical nutrition.

[319]  Anders Gabrielsen,et al.  Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[320]  G. Bedogni,et al.  Prolonged n‐3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non‐alcoholic fatty liver disease: a pilot study , 2006, Alimentary pharmacology & therapeutics.

[321]  P. Libby,et al.  A Novel Prostaglandin E Receptor 4–Associated Protein Participates in Antiinflammatory Signaling , 2006, Circulation research.

[322]  R. Leibel,et al.  CCR2 modulates inflammatory and metabolic effects of high-fat feeding. , 2006, The Journal of clinical investigation.

[323]  W. Janssen,et al.  Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte , 2005, Cell.

[324]  B. Staels,et al.  The Farnesoid X receptor: a molecular link between bile acid and lipid and glucose metabolism. , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[325]  M. Linton,et al.  Conditional Knockout of Macrophage PPARγ Increases Atherosclerosis in C57BL/6 and Low-Density Lipoprotein Receptor–Deficient Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[326]  J. Schölmerich,et al.  Mechanisms of Disease: adipocytokines and visceral adipose tissue—emerging role in nonalcoholic fatty liver disease , 2005, Nature Clinical Practice Gastroenterology &Hepatology.

[327]  D. Greaves,et al.  Mechanisms of Disease: macrophage-derived foam cells emerging as therapeutic targets in atherosclerosis , 2005, Nature Clinical Practice Cardiovascular Medicine.

[328]  D. Schrijvers,et al.  Phagocytosis of Apoptotic Cells by Macrophages Is Impaired in Atherosclerosis , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[329]  Kazuo Kobayashi,et al.  Macrophages in inflammation. , 2005, Current drug targets. Inflammation and allergy.

[330]  E. Ferrannini,et al.  Insulin resistance in non-diabetic patients with non-alcoholic fatty liver disease: sites and mechanisms , 2005, Diabetologia.

[331]  C. Daige,et al.  Macrophage Liver X Receptor Is Required for Antiatherogenic Activity of LXR Agonists , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[332]  W. L. Ruzzo,et al.  Atherosclerotic Plaque Smooth Muscle Cells Have a Distinct Phenotype , 2004, Arteriosclerosis, thrombosis, and vascular biology.

[333]  F. Mach,et al.  Antagonism of RANTES Receptors Reduces Atherosclerotic Plaque Formation in Mice , 2004, Circulation research.

[334]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[335]  L. Tartaglia,et al.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. , 2003, The Journal of clinical investigation.

[336]  E. Fisher,et al.  Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[337]  B. Bennett,et al.  Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis. , 2003, Cardiovascular research.

[338]  M. Burnett,et al.  Effects of MF-tricyclic, a selective cyclooxygenase-2 inhibitor, on atherosclerosis progression and susceptibility to cytomegalovirus replication in apolipoprotein-E knockout mice. , 2003, Journal of the American College of Cardiology.

[339]  B. Brewer,et al.  Liver-specific disruption of PPARgamma in leptin-deficient mice improves fatty liver but aggravates diabetic phenotypes. , 2003, The Journal of clinical investigation.

[340]  I. Charo,et al.  Decreased atherosclerosis in CX3CR1-/- mice reveals a role for fractalkine in atherogenesis. , 2003, The Journal of clinical investigation.

[341]  T. Cohnert,et al.  Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[342]  J. Michel,et al.  Interleukin-10 Deficiency Increases Atherosclerosis, Thrombosis, and Low-density Lipoproteins in Apolipoprotein E Knockout Mice , 2003, Molecular medicine.

[343]  P. Libby.  Inflammation in atherosclerosis , 2002, Nature.

[344]  P. Libby,et al.  Prostaglandin E2 Suppresses Chemokine Production in Human Macrophages through the EP4 Receptor* , 2002, The Journal of Biological Chemistry.

[345]  D. Ramji,et al.  Lipoprotein lipase: structure, function, regulation, and role in disease , 2002, Journal of Molecular Medicine.

[346]  L. Peltonen,et al.  Mutations in two genes encoding different subunits of a receptor signaling complex result in an identical disease phenotype. , 2002, American journal of human genetics.

[347]  Aldons J. Lusis,et al.  Identification of macrophage liver X receptors as inhibitors of atherosclerosis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[348]  A. Lusis,et al.  Identification of 5-Lipoxygenase as a Major Gene Contributing to Atherosclerosis Susceptibility in Mice , 2002, Circulation research.

[349]  T. Willson,et al.  Synthetic LXR ligand inhibits the development of atherosclerosis in mice , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[350]  J. Morrow,et al.  Cyclooxygenase-2 Promotes Early Atherosclerotic Lesion Formation in LDL Receptor–Deficient Mice , 2002, Circulation.

[351]  A. Daugherty,et al.  Interleukin-4 Deficiency Decreases Atherosclerotic Lesion Formation in a Site-Specific Manner in Female LDL Receptor−/− Mice , 2002, Arteriosclerosis, thrombosis, and vascular biology.

[352]  E. Falk,et al.  No Effect of Cyclooxygenase Inhibition on Plaque Size in Atherosclerosis-prone Mice , 2002, Scandinavian cardiovascular journal : SCJ.

[353]  C. Ohlsson,et al.  Interleukin-6-deficient mice develop mature-onset obesity , 2002, Nature Medicine.

[354]  C. Argmann,et al.  Transforming Growth Factor-&bgr;1 Inhibits Macrophage Cholesteryl Ester Accumulation Induced by Native and Oxidized VLDL Remnants , 2001, Arteriosclerosis, thrombosis, and vascular biology.

[355]  D. Bullard,et al.  Essential role of ICAM-1 in mediating monocyte adhesion to aortic endothelial cells. , 2001, American journal of physiology. Cell physiology.

[356]  G. FitzGerald,et al.  Acceleration of atherogenesis by COX-1-dependent prostanoid formation in low density lipoprotein receptor knockout mice , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[357]  M. Gimbrone,et al.  Inhibition of E-Selectin Gene Expression by Transforming Growth Factor β in Endothelial Cells Involves Coactivator Integration of Smad and Nuclear Factor κB–Mediated Signals , 2000, The Journal of experimental medicine.

[358]  R. Zechner,et al.  Role of Macrophage-Derived Lipoprotein Lipase in Lipoprotein Metabolism and Atherosclerosis , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[359]  Mayur B. Patel,et al.  Macrophage Lipoprotein Lipase Promotes Foam Cell Formation and Atherosclerosis in Low Density Lipoprotein Receptor-deficient Mice* , 2000, The Journal of Biological Chemistry.

[360]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[361]  R. Strieter,et al.  Viral IL-10 Gene Transfer Decreases Inflammation and Cell Adhesion Molecule Expression in a Rat Model of Venous Thrombosis1 2 , 2000, The Journal of Immunology.

[362]  M. Bureau,et al.  Protective role of interleukin-10 in atherosclerosis. , 1999, Circulation research.

[363]  M. Linton,et al.  Macrophage lipoprotein lipase promotes foam cell formation and atherosclerosis in vivo. , 1999, The Journal of clinical investigation.

[364]  A. Tedgui,et al.  Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[365]  L. Khaodhiar,et al.  Obesity and its comorbid conditions. , 1999, Clinical cornerstone.

[366]  I. Charo,et al.  Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis , 1998, Nature.

[367]  L. Greenfield,et al.  IL-10 regulates thrombus-induced vein wall inflammation and thrombosis. , 1998, Journal of immunology.

[368]  P. Libby,et al.  Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. , 1998, Molecular cell.

[369]  J. Vane,et al.  Cyclooxygenases 1 and 2. , 1998, Annual review of pharmacology and toxicology.

[370]  A. Lentsch,et al.  In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.

[371]  E. Andreeva,et al.  Subendothelial smooth muscle cells of human aorta express macrophage antigen in situ and in vitro. , 1997, Atherosclerosis.

[372]  J. Dayer,et al.  IL-10 inhibits metalloproteinase and stimulates TIMP-1 production in human mononuclear phagocytes. , 1995, The Journal of clinical investigation.

[373]  J. Gamble,et al.  TGF-β and Endothelial Cells Inhibit VCAM-1 Expression on Human Vascular Smooth Muscle Cells , 1995 .

[374]  Peng Wang,et al.  Interleukin (IL)-10 Inhibits Nuclear Factor B (NFB) Activation in Human Monocytes , 1995, The Journal of Biological Chemistry.

[375]  D. Steinberg,et al.  Role of oxidized low density lipoprotein in atherogenesis. , 1991, The Journal of clinical investigation.

[376]  B. Spiegelman,et al.  Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.

[377]  J. Stephens,et al.  Transcriptional repression of the GLUT4 and C/EBP genes in 3T3-L1 adipocytes by tumor necrosis factor-alpha. , 1991, The Journal of biological chemistry.

[378]  F. B. Cookson.  The origin of foam cells in atherosclerosis. , 1971, British journal of experimental pathology.